New PET scan could reveal hidden HER2 in breast cancer, guiding smarter treatment
NCT ID NCT06732336
First seen Apr 03, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tests a special PET scan that uses a radioactive tracer to find low levels of HER2 protein in metastatic breast cancer. About 40 adults with HER2-low breast cancer will receive an injection of the tracer and be scanned 3-6 days later. The goal is to see if this scan can better detect cancer spread and help doctors choose the most effective targeted therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de recherche du CHUS
RECRUITINGSherbrooke, Quebec, J1H5N4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.